Event-driven securities suits-ones that arise after an issuer has experienced some kind of disaster-have become increasingly prevalent in recent years. These suits are based on the fraud-on-the-market doctrine, a doctrine that ultimately gives rise to the bulk of the damages paid out in settlements and judgments pursuant to private litigation under the U.S. securities laws. The theory behind fraud-on-the-market cases is that when an issuer\u27s share price has been inflated by a Rule-10b-5-violating misstatement, investors who purchased shares at the inflated price have suffered a compensable injury if they still hold the shares after the inflation is gone. Although these event-driven suits differ in important ways from their more tradition...
Event studies, a half-century-old approach to measuring the effect of events on stock prices, are no...
Private suits have long been championed as a necessary mechanism not only to compensate investors fo...
On April 19, 2005, the Supreme Court announced its unanimous opinion in Dura Pharmaceuticals, Inc. v...
Event studies have become increasingly important in securities fraud litigation after the Supreme Co...
An event study is a statistical regression analysis that merely provides one method of examining the...
markdownabstractEvent studies have become increasingly important in securities fraud litigation afte...
We reported in a recent paper that during the 2008-09 financial crisis, for the average firm, idiosy...
In its recent Halliburton decision, the Supreme Court focused on the role of price distortion in me...
Abstract This article explores the economic principles and theories underlying loss causation in th...
Many securities fraud lawsuits follow corporate disasters of some sort or another, claiming that kno...
As we have shown in a series of prior Articles, and as scholars have accepted since, class actions a...
The fraud-on-the-market doctrine adopted in Basic Inc. v. Levinson (“Basic”) allows the plaintiff su...
No coherent doctrinal statement exists for calculating open-market damages for securities fraud cl...
Plaintiffs in securities fraud class actions must prove that defendants’ misconduct caused the inves...
As a critical matter, class action securities fraud plaintiffs employing the fraud-on-the-market the...
Event studies, a half-century-old approach to measuring the effect of events on stock prices, are no...
Private suits have long been championed as a necessary mechanism not only to compensate investors fo...
On April 19, 2005, the Supreme Court announced its unanimous opinion in Dura Pharmaceuticals, Inc. v...
Event studies have become increasingly important in securities fraud litigation after the Supreme Co...
An event study is a statistical regression analysis that merely provides one method of examining the...
markdownabstractEvent studies have become increasingly important in securities fraud litigation afte...
We reported in a recent paper that during the 2008-09 financial crisis, for the average firm, idiosy...
In its recent Halliburton decision, the Supreme Court focused on the role of price distortion in me...
Abstract This article explores the economic principles and theories underlying loss causation in th...
Many securities fraud lawsuits follow corporate disasters of some sort or another, claiming that kno...
As we have shown in a series of prior Articles, and as scholars have accepted since, class actions a...
The fraud-on-the-market doctrine adopted in Basic Inc. v. Levinson (“Basic”) allows the plaintiff su...
No coherent doctrinal statement exists for calculating open-market damages for securities fraud cl...
Plaintiffs in securities fraud class actions must prove that defendants’ misconduct caused the inves...
As a critical matter, class action securities fraud plaintiffs employing the fraud-on-the-market the...
Event studies, a half-century-old approach to measuring the effect of events on stock prices, are no...
Private suits have long been championed as a necessary mechanism not only to compensate investors fo...
On April 19, 2005, the Supreme Court announced its unanimous opinion in Dura Pharmaceuticals, Inc. v...